Literature DB >> 28831593

Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management.

M P Romero-Gómez1, E Cendejas-Bueno2, J García Rodriguez2, J Mingorance2.   

Abstract

We have performed a retrospective, before-after comparison of turnaround time and therapy adjustment parameters before and after the introduction of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) plus mecA polymerase chain reaction (PCR) for the identification of methicillin-resistant Staphylococcus aureus (MRSA) in positive blood cultures. There were 227 episodes of S. aureus bacteremia during the study periods. The pre-MALDI-TOF and post-MALDI-TOF groups included 133 and 94 patients, respectively. The two rapid methods performed sequentially decreased the turnaround time of MRSA identification by nearly 50% (2.06 ± 1.95 vs. 3.95 ± 1.70 days). There was no significant reduction in the length of hospitalization (28.27 ± 32.16 vs. 28.62 ± 28.75 days). In both groups, the adequacy of the empirical antibacterial therapy was similar (59.49% vs. 51.31%), but the optimization of the therapy was more frequent in the post-MALDI-TOF group. Routine implementation of these techniques provides results earlier than conventional methods and increases the proportion of episodes with adequate change of empirical to directed antimicrobial therapy.

Entities:  

Mesh:

Year:  2017        PMID: 28831593     DOI: 10.1007/s10096-017-3086-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia.

Authors:  Abigail M Frye; Catherine A Baker; D Leif Rustvold; Kim A Heath; Jessica Hunt; James E Leggett; Margret Oethinger
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  The effect of the blood culture bottle type in the rate of direct identification from positive cultures by matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry.

Authors:  M P Romero-Gómez; J Mingorance
Journal:  J Infect       Date:  2010-12-25       Impact factor: 6.072

3.  Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Sung-Han Kim; Kye-Hyung Kim; Hong-Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

4.  Antimicrobial stewardship programs: how to start and steer a successful program.

Authors:  Richard H Drew
Journal:  J Manag Care Pharm       Date:  2009-03

5.  Evaluation and use of a rapid Staphylococcus aureus assay by an antimicrobial stewardship program.

Authors:  Tamara L Trienski; Heather L Barrett; Timothy R Pasquale; Joseph R DiPersio; Thomas M File
Journal:  Am J Health Syst Pharm       Date:  2013-11-01       Impact factor: 2.637

Review 6.  Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.

Authors:  Ravina Kullar; James A McKinnell; George Sakoulas
Journal:  Clin Infect Dis       Date:  2014-07-21       Impact factor: 9.079

Review 7.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

8.  Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.

Authors:  Kevin B Laupland; Terry Ross; Daniel B Gregson
Journal:  J Infect Dis       Date:  2008-08-01       Impact factor: 5.226

9.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

10.  Direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry improves appropriateness of antibiotic treatment of bacteremia.

Authors:  Anne L M Vlek; Marc J M Bonten; C H Edwin Boel
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  3 in total

1.  Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007-2015.

Authors:  Eloise D Austin; Sean S Sullivan; Nenad Macesic; Monica Mehta; Benjamin A Miko; Saman Nematollahi; Qiuhu Shi; Franklin D Lowy; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

2.  Optimized identification of microorganisms directly from positive blood cultures by MALDI-TOF to improve antimicrobial treatment.

Authors:  P García Clemente; P Romero-Gómez; J García-Rodríguez; E Cendejas-Bueno
Journal:  Rev Esp Quimioter       Date:  2022-05-23       Impact factor: 2.515

3.  Tailoring antimicrobials in febrile neutropenia: using faster diagnostic and communication tools to improve treatment in the era of extensively resistant pathogens.

Authors:  Ingvar Ludwig Augusto de Souza; Milene Gonçalves Quiles; Bruno Cruz Boettger; Antonio Carlos Campos Pignatari; Paola Cappellano
Journal:  Braz J Infect Dis       Date:  2018-06-28       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.